Rating History for IO Biotech (IOBT) by Piper Sandler
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/26/2026 | Allison M. Bratzel | Downgrade | Neutral (Overweight) |
0.50 (3.00) |
0.48 (0.48) |
0% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/26/2026 | Allison M. Bratzel | Downgrade | Neutral (Overweight) |
0.50 (3.00) |
0.48 (0.48) |
0% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||